Longevity Health Holdings, Inc. Stock-Based Compensation
Longevity Health Holdings, Inc. (XAGE) reported Stock-Based Compensation of $224.69 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- Longevity Health Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $78.76K, a 59.47% decline year-over-year.
- Longevity Health Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $145.93K, a 27.08% increase year-over-year.
- Longevity Health Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $193.71K, a 27.22% decline year-over-year.
- Longevity Health Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $189.93K, a 2.28% increase year-over-year.
- Longevity Health Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $692.79K, a 16.23% decline from fiscal 2024.
- Longevity Health Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $827.04K, a 23.87% increase from fiscal 2023.
- Longevity Health Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $667.68K, a 4.92% increase from fiscal 2022.
- Longevity Health Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $636.37K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $78.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $224.69K 10-Q · filed 2026-08-14 | $418.40K derived: sum of 3 quarters · filed 2026-08-14 | $608.32K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $145.93K 10-Q · filed 2026-05-15 | $339.64K derived: sum of 2 quarters · filed 2026-05-15 | $529.57K derived: sum of 3 quarters · filed 2026-05-15 | $723.89K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $193.71K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $383.64K derived: sum of 2 quarters · filed 2026-03-31 | $577.96K derived: sum of 3 quarters · filed 2026-08-14 | $692.79K 10-K · filed 2026-03-31 |
| 2025-09-30 | $189.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $384.25K derived: sum of 2 quarters · filed 2026-08-14 | $499.08K 10-Q · filed 2025-11-14 | $765.26K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $194.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $309.15K 10-Q · filed 2026-08-14 | $575.33K derived: sum of 3 quarters · filed 2026-08-14 | $761.03K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $114.83K 10-Q · filed 2026-05-15 | $381.01K derived: sum of 2 quarters · filed 2026-05-15 | $566.70K derived: sum of 3 quarters · filed 2026-05-15 | $730.40K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $266.18K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $451.87K derived: sum of 2 quarters · filed 2026-03-31 | $615.57K derived: sum of 3 quarters · filed 2026-03-31 | $827.04K 10-K · filed 2026-03-31 |
| 2024-09-30 | $185.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $349.40K derived: sum of 2 quarters · filed 2025-11-14 | $560.87K 10-Q · filed 2025-11-14 | $623.25K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $163.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $375.17K 10-Q · filed 2025-08-14 | $437.55K derived: sum of 3 quarters · filed 2025-08-14 | $675.31K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $211.47K 10-Q · filed 2025-05-15 | $273.85K derived: sum of 2 quarters · filed 2025-06-17 | $511.61K derived: sum of 3 quarters · filed 2025-06-17 | $698.64K derived: sum of 4 quarters · filed 2025-06-17 |
| 2023-12-31 | $62.38K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-06-17 | $300.14K derived: sum of 2 quarters · filed 2025-06-17 | $487.17K derived: sum of 3 quarters · filed 2025-06-17 | $667.68K 10-K/A · filed 2025-06-17 |
| 2023-09-30 | $237.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $424.79K derived: sum of 2 quarters · filed 2024-11-14 | $605.30K 10-Q · filed 2024-11-14 | $765.37K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $187.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $367.54K 10-Q · filed 2024-08-14 | $527.61K derived: sum of 3 quarters · filed 2024-08-14 | |
| 2023-03-31 | $180.51K 10-Q · filed 2024-05-15 | $340.58K derived: sum of 2 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $160.07K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $636.37K 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $476.29K 10-Q · filed 2023-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |